Payload Information
General Information of This Payload
| Payload ID | PAY0BHFAV |
|||||
|---|---|---|---|---|---|---|
| Name | CN118001423A+ADC3+payload |
|||||
| Synonyms |
CN118001423A+ADC3+payload
Click to Show/Hide
|
|||||
| Structure |
|
|||||
| Formula | C27H29N3O7 |
|||||
| Isosmiles | CC[C@@](C(C=C1C2C(CN31)=C(C4=CC(OCO5)=C5C=C4N2)CCN[C@H]6COCC6)=C(C3=O)CO7)(O)C7=O |
|||||
| InChI |
InChI=1S/C27H29N3O7/c1-2-27(33)19-8-21-24-17(10-30(21)25(31)18(19)12-35-26(27)32)15(3-5-28-14-4-6-34-11-14)16-7-22-23(37-13-36-22)9-20(16)29-24/h7-9,14,24,28-29,33H,2-6,10-13H2,1H3/t14-,24?,27+/m1/s1
|
|||||
| InChIKey |
INTODUAWYBLGOG-JZUMHIKMSA-N
|
|||||
| Pharmaceutical Properties | Molecule Weight |
507.543 |
Polar area |
120.28 |
||
Complexity |
1367.723968 |
xlogp Value |
1.934 |
|||
Heavy Count |
37 |
Rot Bonds |
5 |
|||
Hbond acc |
10 |
Hbond Donor |
3 |
|||
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
CN118001423A ADC3 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | < 50 nM | High NECTIN4 expression (NECTIN4 +++) | ||
| Method Description |
A Cell line test on MDA-MB-468
|
||||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-468 cells | CVCL_0419 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | < 50 nM | High NECTIN4 expression (NECTIN4 +++) | ||
| Method Description |
A Cell line test on SW-780
|
||||
| In Vitro Model | Mouse melanoma | SW-780 cells | CVCL_1728 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | ≈ 50≈200 nM | High NECTIN4 expression (NECTIN4 +++) | ||
| Method Description |
A Cell line test on MCF-7
|
||||
| In Vitro Model | Invasive breast carcinoma | MCF-7 cells | CVCL_0031 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | < 50 nM | High NECTIN4 expression (NECTIN4 +++) | ||
| Method Description |
A Cell line test on LNCAP
|
||||
| In Vitro Model | Prostate carcinoma | LNCaP cells | CVCL_0395 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | < 50 nM | High NECTIN4 expression (NECTIN4 +++) | ||
| Method Description |
A Cell line test on BxPC-3
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
References